Rheumatology Journals

Rheumatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Several agents are available and generally effective for the treatment of gout; however, many are poorly tolerated, or contraindicated in patients with renal, cardiovascular or gastrointestinal disease. Studies have shown that monosodium urate crystals induce interleukin-1 (IL-1) production, by activation of the NALP3 (cryopyrin) inflammasome, which led investigators from Switzerland to determine whether IL-1 blockade could inhibit inflammation induced by monosodium urate crystals


Today in Clinical Pharmacology...keeping you current

A review of the effect of anticonvulsant medications on bone mineral density and fracture risk
The American Journal of Geriatric Pharmacotherapy, 03/19/10

Severe exfoliative dermatitis caused by strontium ranelate: two cases of a new drug reaction
Age and Aging, 03/19/10

A walking model to assess the onset of analgesia in osteoarthritis knee pain
Osteoarthritis and Cartilage , 03/19/10

Today in Gout and Hyperuricemia...keeping you current

Pegloticase for chronic gout
Cochrane Reviews, 03/19/10

Gout, Hyperuricemia, and Parkinson’s Disease: A Protective Effect
Current Rheumatology Reports, 03/19/10

Update on Biology: Uric Acid and the Activation of Immune and Inflammatory Cells
Current Rheumatology Reports, 03/18/10


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address